2023
American College of Radiology initiatives on prostate magnetic resonance imaging quality
Purysko A, Tempany C, Macura K, Turkbey B, Rosenkrantz A, Gupta R, Attridge L, Hernandez D, Garcia-Tomkins K, Bhargavan-Chatfield M, Weinreb J, Larson D. American College of Radiology initiatives on prostate magnetic resonance imaging quality. European Journal Of Radiology 2023, 165: 110937. PMID: 37352683, PMCID: PMC10461171, DOI: 10.1016/j.ejrad.2023.110937.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingProstate magnetic resonance imagingAmerican CollegePatient careACR Appropriateness CriteriaProstate Imaging ReportingQuality Improvement CollaborativeHigh-quality patient careMRI qualityUrogenital RadiologyCenter designationAppropriateness CriteriaPatient outcomesProstate cancerClinical practiceImaging ReportingResonance imagingEuropean SocietyCareControl programsInternational panelMagnetic resonance imaging qualityRadiologyQuality control programPatients
2017
Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy
Lu AJ, Syed JS, Nguyen KA, Nawaf CB, Rosoff J, Spektor M, Levi A, Humphrey PA, Weinreb JC, Schulam PG, Sprenkle PC. Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Urology 2017, 105: 118-122. PMID: 28322902, DOI: 10.1016/j.urology.2017.01.048.Peer-Reviewed Original ResearchConceptsMultiparametric magnetic resonance imagingSignificant prostate cancerProstate cancerNegative predictive valueMagnetic resonance imagingSystematic TRUSNegative mpMRIProstate biopsyNegative multiparametric magnetic resonance imagingPredictive valueResonance imagingClinically Significant Prostate CancerDynamic contrast enhancement sequencesTemplate mapping biopsyPrior negative biopsySystematic prostate biopsyOverall cancer detectionProstate-specific antigenTemplate prostate biopsyProstate cancer detectionDiffusion-weighted imagingCancer detectionBiopsy naïveMapping biopsyProstate volume
2015
Simplified prostate lesion grading for magnetic resonance imaging and improved cancer detection at fusion-targeted prostate biopsy.
Kardos S, Nawaf C, Fan R, Cornfeld D, Weinreb J, Schulam P, Sprenkle P. Simplified prostate lesion grading for magnetic resonance imaging and improved cancer detection at fusion-targeted prostate biopsy. Journal Of Clinical Oncology 2015, 33: 69-69. DOI: 10.1200/jco.2015.33.7_suppl.69.Peer-Reviewed Original ResearchCancer detection rateOverall cancer detection rateSignificant prostate cancerProstate cancerSystematic biopsyProstate biopsyFusion biopsyCommon solid organ malignancyEndorectal coilCores TRUS biopsyPrior negative biopsySolid organ malignanciesFusion prostate biopsyCochran-Armitage trend testCause of cancerMagnetic resonance imagingReal-time ultrasoundArmitage trend testAbnormal DRELesion stratificationElevated PSAOrgan malignanciesLesion gradingNegative biopsyTRUS biopsy
2002
Magnetic Resonance Evaluation of the Urethra and Lower Genitourinary Tract in Symptomatic Women
Israel G, Lee V, Resnick D, Lavelle M, Krinsky G, Nitti V, Weinreb J. Magnetic Resonance Evaluation of the Urethra and Lower Genitourinary Tract in Symptomatic Women. Journal Of Women's Imaging 2002, 4: 165-172. DOI: 10.1097/00130747-200211000-00003.Peer-Reviewed Original ResearchMR imagingCavernous hemangiomaMR examinationsLower urinary tractPhysical examination findingsSquamous cell carcinomaPelvic floor dysfunctionContrast-enhanced T1-weighted imagesVaginal wall cystTethered spinal cordMR imaging findingsMagnetic resonance evaluationLower Genitourinary TractMagnetic resonance imagingT2-weighted imagesT1-weighted imagesChart reviewPelvic ultrasonographyIntravenous pyelographySymptomatic womenExamination findingsImaging findingsPathology findingsCell carcinomaUrinary tractIn Vitro MR Imaging of Placentas from Women at Risk for Placental Insufficiency
Phillips R, Krinsky G, Kanzer G, Gokhale H, Weinreb J. In Vitro MR Imaging of Placentas from Women at Risk for Placental Insufficiency. Journal Of Women's Imaging 2002, 4: 13-16. DOI: 10.1097/00130747-200202000-00005.Peer-Reviewed Original ResearchPlacental infarctionPlacental insufficiencyMR imagingPlacental anatomyEx vivo MR imagingIntrauterine growth retardationMR signal abnormalitiesArea of infarctionNormal anatomic featuresMagnetic resonance imagingT2-weighted sequencesMultiple infarctsPlacental infarctsPathologic correlatesSignal abnormalitiesFocal abnormalitiesHistologic examinationCongenital abnormalitiesAnatomic featuresResonance imagingGrowth retardationPlacentaInfarctionInfarctsAbnormalities
2000
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Schmiedl U, Brown J, Borrello J, Lee J, Semelka R, Mattrey R, Dachman A, Saini S, Harms S, Mitchell D, Anderson M, Halford H, Bennett W, Young S, Rifkin M, Gay S, Ballerini R, Sherwin P, Robison R. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. Journal Of Magnetic Resonance Imaging 2000, 12: 689-701. PMID: 11050638, DOI: 10.1002/1522-2586(200011)12:5<689::aid-jmri5>3.0.co;2-z.Peer-Reviewed Original ResearchConceptsUnenhanced magnetic resonance imagingMagnetic resonance imagingMangafodipir trisodium injectionFinal diagnosisMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsContrast-enhanced magnetic resonance imagingInjection of MnDPDPPatient's final diagnosisHepatic magnetic resonance imagingComputed tomography examinationEnhanced magnetic resonance imagingFocal liver diseaseAdditional diagnostic informationFocal liver lesionsLiver diseaseEarly imagingMRI evaluationHepatic massClinical trialsTomography examinationIntravenous administrationPatient managementRadiologic diagnosisSiderotic Nodules at MR Imaging: Regenerative or Dysplastic?
Krinsky G, Lee V, Nguyen M, Rofsky N, Theise N, Morgan G, Teperman L, Weinreb J. Siderotic Nodules at MR Imaging: Regenerative or Dysplastic? Journal Of Computer Assisted Tomography 2000, 24: 773-776. PMID: 11045701, DOI: 10.1097/00004728-200009000-00019.Peer-Reviewed Original ResearchConceptsSiderotic nodulesMR imagingOrthotopic liver transplantationMagnetic resonance imagingSiderotic regenerative nodulesCirrhotic patientsLiver transplantationHypointense nodulesPathologic correlationRegenerative nodulesPatientsResonance imagingPrussian blue iron stainIron stainGradient echo pulse sequenceNodulesImagingMacronodularTransplantationSafety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety)
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Semelka R, Brown J, Borrello J, Lee J, Mattrey R, Dachman A, Saini S, Harmon B, Fenstermacher M, Pelsang R, Harms S, Mitchell D, Halford H, Anderson M, Johnson C, Francis I, Bova J, Kenney P, Klippenstein D, Foster G, Turner D, Stillman A, Nelson R, Young S, Patt R, Rifkin M, Seltzer S, Gay S, Robison R, Sherwin P, Ballerini R. Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety). Journal Of Magnetic Resonance Imaging 2000, 12: 186-197. PMID: 10931579, DOI: 10.1002/1522-2586(200007)12:1<186::aid-jmri21>3.0.co;2-2.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal PainAdultAgedAged, 80 and overCardiovascular DiseasesContrast MediaDiagnosis, DifferentialEdetic AcidFemaleHumansImage EnhancementInjections, IntravenousLiver CirrhosisLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedPainPregnancyPyridoxal PhosphateRisk AssessmentSensitivity and SpecificityVomitingConceptsMagnetic resonance imagingMangafodipir trisodium injectionAdverse eventsMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsUnenhanced magnetic resonance imagingInjection of MnDPDPInjection-associated discomfortSerious adverse eventsShort-term safetyHepatic magnetic resonance imagingComputed tomography examinationSignificant short-term riskShort-term riskFocal liver lesionsClinical trialsTomography examinationLaboratory valuesLiver lesionsResonance imagingVital signsPatientsMnDPDPInjection
1995
MR imaging of the breast.
Weinreb J, Newstead G. MR imaging of the breast. Radiology 1995, 196: 593-610. PMID: 7644617, DOI: 10.1148/radiology.196.3.7644617.Peer-Reviewed Original ResearchConceptsBreast MR imagingMR imagingMR imaging-guided biopsyPossible clinical roleImaging-guided biopsyContrast-enhanced MR imagingContrast material-enhanced imagingMagnetic resonance imagingCancer screeningBreast diseaseBreast cancerClinical roleClinical practiceBreast implantsResonance imagingRoutine useBreast massesTreatment planningBiopsyBreastImagingImaging techniquesCancerVariety of rolesDisease
1994
Controversies in breast MRI.
Weinreb J, Newstead G. Controversies in breast MRI. Magnetic Resonance Quarterly 1994, 10: 67-83. PMID: 7986702.Peer-Reviewed Original ResearchComparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions initial findings
Birnbaum B, Weinreb J, Fernandez M, Brown J, Rofsky N, Young S. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions initial findings. Clinical Imaging 1994, 18: 21-27. PMID: 8180855, DOI: 10.1016/0899-7071(94)90141-4.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingMn-DPDPMore lesionsRetrospective multi-institutional studyExtensive metastatic diseaseHepatic magnetic resonance imagingMulti-institutional studyFocal hepatic diseaseFocal liver lesionsN'-dipyridoxylethylenediamineMetastatic diseaseIntravenous bolusDose groupFatty liverHepatic diseaseComparison of ContrastHepatic lesionsComputed tomographyLiver lesionsCT studiesPatientsMumol/Resonance imagingBolus contrastLesions
1993
Use of the Magnetic Resonance Contrast Agent Gadodiamide in the Central Nervous System Results of a Multicenter Trial
SZE G, BRANT-ZAWADZKI M, McNAMARA M, HAUGHTON V, KUMAR A, MARAVILLA K, AISEN A, DREISBACH J, BRADLEY W, WEINREB J, DRAYER B, TSURUDA J, HESSELINK J, JOHNSON C, ZIMMERMAN R, WEINGAST G. Use of the Magnetic Resonance Contrast Agent Gadodiamide in the Central Nervous System Results of a Multicenter Trial. Investigative Radiology 1993, 28: s49-s55. PMID: 8486504, DOI: 10.1097/00004424-199303001-00006.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingPhase II/III clinical trialsVital signsCentral nervous system resultsSignificant adverse eventsNervous system resultsNonionic contrast agentsVisualization of lesionsPreinjection imagesAdverse eventsNeurologic statusMulticenter trialClinical statusMulticenter studyClinical trialsPatient's vital signsMRI scansGadodiamide injectionPatientsResonance imagingSafety parametersContrast enhancementInjectionTrialsSpineAortic aneurysm and dissection: normal MR imaging and CT findings after surgical repair with the continuous-suture graft-inclusion technique.
Rofsky N, Weinreb J, Grossi E, Galloway A, Libes R, Colvin S, Naidich D. Aortic aneurysm and dissection: normal MR imaging and CT findings after surgical repair with the continuous-suture graft-inclusion technique. Radiology 1993, 186: 195-201. PMID: 8416564, DOI: 10.1148/radiology.186.1.8416564.Peer-Reviewed Original ResearchConceptsGraft inclusion techniqueComputed tomographyMR imagingAortic aneurysmContrast material-enhanced computed tomographyMaterial-enhanced computed tomographyContrast-enhanced computed tomographyPostoperative imaging findingsNormal MR imagingPostoperative imaging evaluationMagnetic resonance imagingAsymptomatic patientsAortic dissectionCT findingsImaging findingsIntimal flapSurgical repairImaging evaluationSurgical techniqueAnatomic consequencesPatientsNormal rangeResonance imagingGraftDissection
1992
Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Rofsky N, Weinreb J. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent. Magnetic Resonance Quarterly 1992, 8: 156-68. PMID: 1390058.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingMn-DPDPN'-dipyridoxylethylenediamineClinical experienceNon-enhanced T1Significant adverse eventsEnhanced magnetic resonance imagingManganese NT2-weighted imagesAdverse eventsHepatocellular originClinical trialsContrast agentsHepatobiliary agentsResonance imagingLiver imagingFavorable resultsLesion detectionNew contrast agentsIssues of safetyImaging techniquesAgentsImagingOptimal methodNumerous strategiesHepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Bernardino M, Young S, Lee J, Weinreb J. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 1992, 183: 53-8. PMID: 1549694, DOI: 10.1148/radiology.183.1.1549694.Peer-Reviewed Original ResearchConceptsMn-DPDPMore lesionsAdditional lesionsT1-weighted imagesDose groupSerious side effectsMagnetic resonance imagingT2-weighted imagesFocal hepatic diseaseN'-dipyridoxylethylenediamineIntravenous bolusHepatic diseaseMultiinstitutional studyPatientsSide effectsLesionsResonance imagingHepatic MRManganese NImaging parametersContrast agentsImagingGroupInfusionBolus
1991
Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
Sze G, Brant-Zawadzki M, Haughton V, Maravilla K, McNamara M, Kumar A, Aisen A, Dreisbach J, Bradley W, Weinreb J. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991, 181: 693-9. PMID: 1947084, DOI: 10.1148/radiology.181.3.1947084.Peer-Reviewed Original ResearchConceptsCentral nervous systemGadodiamide injectionNervous systemMR imagingSerious adverse eventsContrast material enhancementVisualization of lesionsMagnetic resonance imagingNeurologic statusAdverse eventsMulticenter studyLaboratory valuesPatientsResonance imagingVital signsLesionsUnenhanced imagesSpinePhase IIInjectionMaterial enhancementContrast agentsMR imagesGadolinium chelate complexesImagingContrast-Enhanced Magnetic Resonance Imaging of the Liver with Mn-DPDP for Known or Suspected Focal Hepatic Disease
BERNARDINO M, YOUNG S, LEE J, WEINREB J. Contrast-Enhanced Magnetic Resonance Imaging of the Liver with Mn-DPDP for Known or Suspected Focal Hepatic Disease. Investigative Radiology 1991, 26: s148-s149. PMID: 1808113, DOI: 10.1097/00004424-199111001-00050.Peer-Reviewed Original ResearchThoracic Magnetic Resonance Imaging
Weinreb J, Naidich D. Thoracic Magnetic Resonance Imaging. Clinics In Chest Medicine 1991, 12: 33-54. PMID: 2009744, DOI: 10.1016/s0272-5231(21)00725-5.Peer-Reviewed Original ResearchConceptsProcedure of choiceContrast mediumThoracic magnetic resonance imagingEnlarged lymph nodePlain chest radiographIntravenous contrast mediumMagnetic resonanceMagnetic resonance imagingUse of MRThoracic neoplasiaHilar tumorsPancoast tumorVenous obstructionRenal failureLymph nodesAortic diseaseCystic lesionsComplex cystsCentral airwaysHilar vesselsInvasive studiesMediastinal pathologyMediastinal vesselsChest radiographsChest wall
1990
Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT.
Birnbaum B, Weinreb J, Megibow A, Sanger J, Lubat E, Kanamuller H, Noz M, Bosniak M. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology 1990, 176: 95-101. PMID: 2191377, DOI: 10.1148/radiology.176.1.2191377.Peer-Reviewed Original ResearchConceptsSingle-photon emission CTMR imagingHepatic hemangiomaPerfusion blood pool mismatchMajor hepatic vesselsCases MR imagingT2-weighted spin-echo MR imagesPhoton emission CTMagnetic resonance imagingDiagnosis of lesionsLesion signal intensityRed blood cellsDefinitive diagnosisHypervascular metastasesTc-99mHemangiomaSpin-echo MR imagesEmission CTHepatic vesselsResonance imagingBlood cellsMagnetic resonance imaging of the kidneys and adrenals
Lubat K, Weinreb J. Magnetic resonance imaging of the kidneys and adrenals. Topics In Magnetic Resonance Imaging 1990, 2: 17-36. PMID: 2161246, DOI: 10.1097/00002142-199006000-00005.Peer-Reviewed Original ResearchConceptsComplex cystic renal massesRenal transplant failureMalignant adrenal massesLocalization of pheochromocytomaRenal cell carcinomaImaging of childrenMedical renal diseaseCystic renal massesMagnetic resonance imagingVascular involvementAdrenal massesCT findingsRenal diseaseTransplant failureAdrenal anatomyCell carcinomaRenal massesAdjacent organsSensitive modalityClinical utilityResonance imagingWilms tumorMRITumorsDirect extension